Substrate Mapping Alters Ventricular Tachycardia Inducibility.


Journal

Circulation. Arrhythmia and electrophysiology
ISSN: 1941-3084
Titre abrégé: Circ Arrhythm Electrophysiol
Pays: United States
ID NLM: 101474365

Informations de publication

Date de publication:
02 2023
Historique:
pubmed: 6 1 2023
medline: 25 2 2023
entrez: 5 1 2023
Statut: ppublish

Résumé

Initiation of ventricular tachycardia (VT) by programmed electrical stimulation (PES) has an important role to allow mapping and assess ablation end points. We hypothesized that substrate mapping may alter VT inducibility by mechanical bumping of critical sites. Subjects with left ventricular scar-related VT that was inducible by PES who were undergoing ablation were included. PES was repeated after substrate mapping (Group I) or after time under sedation/anesthesia during which additional imaging and transeptal puncture were performed without substrate mapping (Group II). The response to the second PES was categorized as type I if the same VT was induced, type II if a different VT was induced, and type III if VT was not inducible. Twenty-eight patients (median age 66 years, 61% ischemic cardiomyopathy), 14 in Group I and 14 in Group II, were included. Age, time between initial and second PES, type of cardiomyopathy, ejection fraction, and anesthesia methods were not different between the 2 groups. Initial VT cycle length, however, was shorter in Group I (305 millisecond [range, 235-600] versus 350 millisecond [range, 235-600], Mechanical effects of substrate mapping commonly alter inducibility of VT. This has important implications for catheter ablation procedure planning and acute assessment of outcome and can potentially account for some recurrent VTs that are not recognized at the time of the procedure.

Sections du résumé

BACKGROUND
Initiation of ventricular tachycardia (VT) by programmed electrical stimulation (PES) has an important role to allow mapping and assess ablation end points. We hypothesized that substrate mapping may alter VT inducibility by mechanical bumping of critical sites.
METHODS
Subjects with left ventricular scar-related VT that was inducible by PES who were undergoing ablation were included. PES was repeated after substrate mapping (Group I) or after time under sedation/anesthesia during which additional imaging and transeptal puncture were performed without substrate mapping (Group II). The response to the second PES was categorized as type I if the same VT was induced, type II if a different VT was induced, and type III if VT was not inducible.
RESULTS
Twenty-eight patients (median age 66 years, 61% ischemic cardiomyopathy), 14 in Group I and 14 in Group II, were included. Age, time between initial and second PES, type of cardiomyopathy, ejection fraction, and anesthesia methods were not different between the 2 groups. Initial VT cycle length, however, was shorter in Group I (305 millisecond [range, 235-600] versus 350 millisecond [range, 235-600],
CONCLUSIONS
Mechanical effects of substrate mapping commonly alter inducibility of VT. This has important implications for catheter ablation procedure planning and acute assessment of outcome and can potentially account for some recurrent VTs that are not recognized at the time of the procedure.

Identifiants

pubmed: 36602818
doi: 10.1161/CIRCEP.122.010889
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e010889

Commentaires et corrections

Type : CommentIn

Auteurs

Asad A Aboud (AA)

Ascension Saint Thomas Heart Center, Nashville, TN (A.A.A.).

Giovanni Davogustto (G)

Vanderbilt Heart and Vascular Institute, Nashville, TN (G.D., T.D.R., K.T., G.F.M., W.G.S., A.K.).

Oluwaseun Adeola (O)

Methodist Hospital - Cardiology Clinic of San Antonio, TN (O.A.).

Travis D Richardson (TD)

Vanderbilt Heart and Vascular Institute, Nashville, TN (G.D., T.D.R., K.T., G.F.M., W.G.S., A.K.).

Kenichi Tokutake (K)

Vanderbilt Heart and Vascular Institute, Nashville, TN (G.D., T.D.R., K.T., G.F.M., W.G.S., A.K.).

Gregory F Michaud (GF)

Vanderbilt Heart and Vascular Institute, Nashville, TN (G.D., T.D.R., K.T., G.F.M., W.G.S., A.K.).

William G Stevenson (WG)

Vanderbilt Heart and Vascular Institute, Nashville, TN (G.D., T.D.R., K.T., G.F.M., W.G.S., A.K.).

Arvindh Kanagasundram (A)

Vanderbilt Heart and Vascular Institute, Nashville, TN (G.D., T.D.R., K.T., G.F.M., W.G.S., A.K.).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH